PYRAZOL-MAGL-INHIBITOREN
European patent · EP4198024 · In force
Register entry
- Publication number
- EP4198024
- Application number
- EP23151106
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- May 22, 2018
- Published
- Jun 21, 2023
- Granted
- Aug 5, 2026
- Protection ends at the latest
- May 21, 2038
- Next annual fee due
- May 31, 2027
- IPC classes
- C07D 231/14 (2006.01)C07D 401/06 (2006.01)C07D 401/12 (2006.01)A61K 31/4155 (2006.01)A61K 31/496 (2006.01)A61P 1/16 (2006.01)A61P 25/06 (2006.01)A61P 29/00 (2006.01)A61P 37/02 (2006.01)C07D 403/06 (2006.01)C07D 403/12 (2006.01)C07D 519/00 (2006.01)C07D 491/048 (2006.01)C07D 403/14 (2006.01)C07D 413/12 (2006.01)C07D 413/14 (2006.01)C07D 417/12 (2006.01)C07D 417/14 (2006.01)C07D 451/02 (2006.01)C07D 487/04 (2006.01)C07D 471/10 (2006.01)
- Priority
- US 201762510213 P 23.05.2017
- Divided from
- EP18806431
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Aug 5, 2026
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 05.08.2026
Parties
Inventor
Grice, Cheryl A.
San Diego, 9121, US
Wiener, John J.M.
San Diego, 9121, US
Duncan, Katharine K.
San Diego, 9121, US
Weber, Olivia D.
San Diego, 9121, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.